Keyword: inflammatory diseases

News

Resilience and Mubadala in Biopharma Venture

17.01.2023 -

US biopharma manufacturing and technology company National Resilience has entered into an agreement with Abu Dhabi investor Mubadala Investment Company to build a...

News

Gilead Buys Oxford Spin-out MiroBio

10.08.2022 -

Gilead Sciences has agreed to acquire MiroBio, a privately held UK biotech focused on treating inflammatory diseases, for about $405 million in cash.

News

Boehringer Wins Europe’s First Biosimilar Approval

21.11.2017 - Boehringer Ingelheim has been granted its first biosimilar approval in Europe, receiving authorization to market Cyltezo for treating a variety of chronic inflammatory diseases in...